Skip to main content

Medications for Pneumonia with Cystic Fibrosis

Pneumonia is a potentially serious infection of the lungs caused by bacteria, viruses or rarely fungi. Patients with Cystic fibrosis (an inherited disease that causes thick, sticky mucus to build up in the lungs, and other areas of the body) are prone to developing recurrent chest infections including pneumonia because the mucus in the lungs is thicker and not cleared so easily. This can trap bacteria and lead to infection and inflammation.

Drugs used to treat Pneumonia with Cystic Fibrosis

The medications listed below are related to or used in the treatment of this condition.

Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
Cipro Rate Add review Rx C N
Generic name:
ciprofloxacin systemic
Drug class:
quinolones and fluoroquinolones
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
ciprofloxacin 9.0 1 review for ciprofloxacin to treat Pneumonia with Cystic Fibrosis Rx C N
Generic name:
ciprofloxacin systemic
Brand names:
Cipro, Cipro I.V., Cipro XR
Drug class:
quinolones and fluoroquinolones
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
ceftazidime Rate Add review Rx B N
Generic name:
ceftazidime systemic
Brand names:
Fortaz, Tazicef
Drug class:
third generation cephalosporins
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
cilastatin / imipenem Rate Add review Rx C N
Generic name:
cilastatin / imipenem systemic
Brand name:
Primaxin IV
Drug class:
carbapenems
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Cipro I.V. Rate Add review Rx C N
Generic name:
ciprofloxacin systemic
Drug class:
quinolones and fluoroquinolones
For consumers:
dosage, interactions, side effects
Fortaz Rate Add review Rx B N
Generic name:
ceftazidime systemic
Drug class:
third generation cephalosporins
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Cayston Rate Add review Rx B N
Generic name:
aztreonam systemic
Drug class:
miscellaneous antibiotics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Cipro XR Rate Add review Rx C N
Generic name:
ciprofloxacin systemic
Drug class:
quinolones and fluoroquinolones
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
aztreonam Rate Add review Rx B N
Generic name:
aztreonam systemic
Brand name:
Cayston
Drug class:
miscellaneous antibiotics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
piperacillin Rate Add review Rx B N
Generic name:
piperacillin systemic
Drug class:
antipseudomonal penicillins
For consumers:
dosage, interactions, side effects
Primaxin IV Rate Add review Rx C N
Generic name:
cilastatin / imipenem systemic
Drug class:
carbapenems
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Tazicef Rate Add review Rx B N
Generic name:
ceftazidime systemic
Drug class:
third generation cephalosporins
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information

Frequently asked questions

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.